UBS O'Connor’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,145,000
| Closed | -$28.3M | – | 936 |
|
|
2022
Q2 | $28.3M | Buy |
+10,145,000
| New | +$28.3M | 0.29% | 40 |
|
|
2022
Q1 | – | Sell |
-8,275,000
| Closed | -$75.6M | – | 92 |
|
|
2021
Q4 | $75.6M | Buy |
8,275,000
+1,641,084
| +25% | +$15M | 0.73% | 16 |
|
|
2021
Q3 | $70.9M | Buy |
6,633,916
+2,208,916
| +50% | +$23.6M | 0.56% | 20 |
|
|
2021
Q2 | $68.7M | Buy |
4,425,000
+2,100,000
| +90% | +$32.6M | 0.61% | 23 |
|
|
2021
Q1 | $37.7M | Buy |
2,325,000
+1,725,000
| +288% | +$28M | 0.54% | 21 |
|
|
2020
Q4 | $12.7M | Sell |
600,000
-50,000
| -8% | -$1.06M | 0.26% | 60 |
|
|
2020
Q3 | $9.63M | Sell |
650,000
-25,000
| -4% | -$371K | 0.24% | 59 |
|
|
2020
Q2 | $9.93M | Sell |
675,000
-725,000
| -52% | -$10.7M | 0.22% | 107 |
|
|
2020
Q1 | $16.4M | Buy |
+1,400,000
| New | +$16.4M | 0.34% | 60 |
|
|
2019
Q3 | – | Sell |
-100,000
| Closed | -$1.86M | – | 277 |
|
|
2019
Q2 | $1.86M | Buy |
+100,000
| New | +$1.86M | 0.04% | 146 |
|